No Data
We Think Fujian Wanchen Biotechnology Group (SZSE:300972) Can Stay On Top Of Its Debt
The Chairman is under investigation, Wanchen Group: the matters involved are unrelated to the company's Operation | Brief announcement.
① Wancheng Group announces that Chairman Wang Jiankun has been placed under detention and is under investigation; the matters involved are unrelated to the company, and so far the company has not been asked to assist in the investigation. ② Reviewing Wang Jiankun's tenure, during his time, he promoted the transformation of Wancheng Group from edible mushroom cultivation to wholesale snack business.
Gelonghui announcement highlights | GD Power Development: Plans to invest 4.508 billion yuan to construct the Dadu River Eagle Rock Level 1 Hydropower Station project; Tianhe Magnetic Material: No humanoid Siasun Robot&Automation related business at prese
【Hot Topic】EmbedWay Technologies (603496.SH): The company's Ascend Deepseek integrated machine is still in the prototype development and promotion stage. Foshan Golden Milky Way Intelligent Equipment (300619.SZ) recently engaged in deep cooperation with Microvast in the Solid State Battery field. Tianhe Magnetic Materials (603072.SH): There is currently no business related to humanoid robots. Shanghai Emperor of Cleaning Hi-Tech (603200.SH): The Solid State Battery related business has not yet obtained bulk Orders, and has not yet formed stable long-term revenue. Zhejiang Tengen Electrics (605066.SH): The revenue from products applied in the Industry of robots is less than 2 million yuan, accounting for a very small proportion.
Fujian Wanchen Biotechnology Group (SZSE:300972) Knows How To Allocate Capital Effectively
Can Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Maintain Its Strong Returns?
Wanchen Group: Fujian Wanchen Biotechnology Group Co., Ltd. 2024 Annual Performance Forecast
Potential Upside For Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Not Without Risk